Ocular Therapeutix Inc (OCUL)
Healthcare
Biotechnology
8.20 $
-3.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Ocular Therapeutix Inc (OCUL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -205 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20 | -34 | -34 | -50 | -49 | -78 | -54 | -66 | -60 | -70 | -135 | -205 | |
| 0.5 | 0.8 | 0.9 | 1.6 | 2.3 | 2.5 | 2.8 | 2.4 | 2.1 | 3.0 | 3.8 | 4.3 | |
| 2.6 | 4.6 | 6.0 | 7.3 | 7.5 | 8.8 | 7.5 | 15 | 17 | 18 | 33 | 43 | |
| 2.6 | 4.3 | 7.2 | 7.3 | 7.5 | 4.5 | 94 | -59 | 3.1 | – | – | – | |
| 2.2 | 0.5 | 2.1 | 3.6 | 0.6 | -1.9 | 1.2 | -2.9 | 1.3 | -7.4 | -10 | 7.7 | |
| 1.3 | 1.8 | 1.9 | 8.3 | 1.9 | 2.2 | 0.8 | 1.2 | 3.7 | 6.1 | 1.3 | 12 | |
| -39 | -39 | 36 | 27 | -1.9 | -2.2 | -0.8 | -1.2 | -3.7 | -6.1 | -1.3 | -12 | |
| 15 | 2.1 | 0.0 | 4.4 | 0.3 | 37 | 0.7 | 0.7 | – | 53 | – | – | |
| 0.1 | 0.2 | 1.1 | 0.3 | 0.3 | 0.5 | 0.7 | 1.0 | 0.9 | 0.9 | 1.0 | 1.6 | |
| 12 | 0.4 | 2.4 | 2.4 | 6.4 | 37 | -0.4 | -0.4 | 0.0 | 56 | 0.0 | 0.0 | |
| 79 | 66 | 0.6 | 32 | 69 | 75 | 228 | 2.9 | 1.5 | 170 | 332 | 562 | |
| 20 | -6.6 | 2.2 | 8.6 | 18 | -4.5 | 174 | -64 | -62 | 94 | 196 | 345 | |
| -22 | -36 | -36 | -59 | -51 | -80 | -54 | -67 | -63 | -76 | -136 | -217 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.